299. Cystic fibrosis
1,592 clinical trials,   1,539 drugs   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
8 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03965832
(ClinicalTrials.gov)
May 24, 201924/5/2019HFNT During Exercise in CFA Pilot Study to Evaluate the Feasibility of Using High-flow Nasal Therapy During Exercise in Patients With Cystic Fibrosis and Severe Lung DiseaseCystic FibrosisDevice: HFNT during exercise;Device: Standard oxygen therapy/RAThe Leeds Teaching Hospitals NHS TrustNULLRecruiting18 YearsN/AAll20N/AUnited Kingdom
2NCT03902236
(ClinicalTrials.gov)
March 1, 20191/4/2019Reaction Time and Postural Control in Individuals With Cystic Fibrosis and BronchiectasisEvaluation of Reaction Time and Postural Control in Individuals With Cystic Fibrosis and BronchiectasisCystic Fibrosis;BronchiectasisOther: Reaction Time and Postural Control;Other: Muscle oxygenation;Other: Exercise capacity;Other: BalanceHacettepe UniversityNULLRecruiting6 Years18 YearsAll60Turkey
3NCT02684552
(ClinicalTrials.gov)
February 201612/2/2016Non Invasive Ventilation During Physical Training in Cystic FibrosisPhysiotherapist in Charge of the StudyCystic FibrosisDevice: Non invasive ventilation;Device: OxygenKarolinska University HospitalNULLCompleted18 Years90 YearsBoth8N/ASweden
4NCT02262871
(ClinicalTrials.gov)
December 20147/10/2014HFN Versus NIV in Cystic Fibrosis. The HIFEN StudyRandomized Cross-over Physiologic Study of High Flow Nasal Oxygen Cannula Versus Non-invasive Ventilation in Cystic Fibrosis. The HIFEN StudyCystic FibrosisDevice: High flow nasal oxygen cannula;Device: Noninvasive ventilationSt. Michael's Hospital, TorontoNULLCompleted18 YearsN/AAll15N/ACanada
5NCT01586728
(ClinicalTrials.gov)
October 201218/1/2012Oxygen Therapy in Cystic FibrosisIndication and Benefits of Nocturnal Oxygen Therapy in Cystic FibrosisCystic FibrosisOther: Air - oxygen;Other: Oxygen - AirAssistance Publique - Hôpitaux de ParisVaincre la MucoviscidoseTerminated6 YearsN/ABoth8N/AFrance
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT01731015
(ClinicalTrials.gov)
January 201216/11/2012Imaging Lung Function Using Oxygen Enhanced MRIA Pilot Study for Evaluation of Regional Lung Function in Normal Subjects and Subjects With Airway and Lung Disorders Using 1H Magnetic Resonance Imaging With Oxygen as a Contrast AgentCOPD;Asthma;Cystic Fibrosis;Emphysema;Small Airways DiseaseDrug: Medical Grade OxygenHal C CharlesNULLCompleted18 Years90 YearsBoth15Phase 1United States
7NCT01710449
(ClinicalTrials.gov)
September 200917/10/2012Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With OxygenEvaluation of Regional Ventilation in Normal Subjects and Subjects With Airway and Lung Disorders (COPD, Asthma, Emphysema, Small Airway Disease and Cystic Fibrosis) Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen.COPD;Asthma;Cystic Fibrosis;Emphysema;Small Airways DiseasesDrug: perfluorinated gas/oxygen mixtureHal C CharlesNULLCompleted18 YearsN/ABoth44Phase 1United States
8NCT00157183
(ClinicalTrials.gov)
March 20039/9/2005Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen DesaturationNon-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen DesaturationCystic FibrosisDevice: Nocturnal oxygen , nocturnal bi-level positive pressure ventilationBayside HealthNational Health and Medical Research Council, Australia;Monash University;Cystic Fibrosis AustraliaCompleted18 Years75 YearsBoth59Phase 1;Phase 2Australia